top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Novel Treatment Strategies for Glioblastoma
Novel Treatment Strategies for Glioblastoma
Autore Stylli Stanley
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (268 p.)
Soggetto topico Medicine
Soggetto non controllato glioblastoma
glioma
temozolomide
radiotherapy
immunotherapy
novel therapy
personalized treatment
drug repurposing
invasion
invadopodia
ion channels
gene therapy
viral vectors
brain tumor
nanomedicine
cancer stem cell
targeted therapy
brain cancer
cell cycle
differentiation
proliferation
RAS
SRGAP2
stem cell
TP53
glioblastoma multiforme
GBM
nerve/glial antigen 2
NG2
CK2
CX-4945
migration
CRISPR/Cas9
anticancer
anti-angiogenesis
thyrointegrin αvβ3
PEG
triazole tetrac
P-bi-TAT
P-m-TAT
tetrac
one-carbon metabolism
de novo purine synthesis
metabolic reprogramming
metabolic treatment
vaccine
immune checkpoint inhibitors
chimeric antigen receptor (CAR) T cells
glioblastoma (GB)
prolyl-oligopeptidase (POP)
vascular endothelial growth factor (VEGF)
transforming growth factor-β (TGF-β)
angiopoietin (Ang)
endothelial nitric oxide synthase (eNOS)
newly diagnosed glioblastoma
recurrent glioblastoma
new trial design
drug-inducible gene expression
Mardepodect
Regorafenib
drug targets
tumor antigens
renin-angiotensin system
pluripotent stem cells
organoids
cancer stem cells
cancer stem cell niche
tumor microenvironment
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557363703321
Stylli Stanley  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Precision Medicine in Solid Tumors
Precision Medicine in Solid Tumors
Autore Dey Nandini
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (304 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato pediatric tumors
tumor mutational burden
TMB
whole-exome sequencing
gene panel sequencing
immune checkpoint inhibitors
glioblastoma prognosis
overall survival
extent of resection
random forest
Decision tree
personalized precision oncology
circulating free DNA
liquid biopsy
epidermal growth factor receptor
tyrosine kinase inhibitor
osimertinib
comprehensive genomic profiling
molecular genotyping
intratumor heterogeneity
multiple biopsies
tumor evolution
clonality classification
strategic therapeutic intervention
thymoma
driver mutation
sequencing
molecular barcoding
EGFR mutation
EGFR-TKI
cfDNA
NGS
digital enrichment
next-generation sequencing
solid cancer
universal health-care system
precision medicine
presumed germline findings
clinical guideline
non-small cell lung cancer
outcome
adjuvant chemotherapy
anaplastic lymphoma receptor tyrosine kinase
HNSCC
ctDNA
tDNA
DDR genes
PARP inhibitors
new drug development
next-generation sequencing (NGS)
open data
regulatory reform
tumor profiling test
triple-negative breast cancer (TNBC)
breast cancer
targeted therapy
TNBC subtypes
immunotherapy
cancer
screening
smoking
electronic records
PD-L1
cancer-associated fibroblasts
resistance
chemotherapy
CTC
immunocytochemistry
parallel double-detection
laboratory-friendly
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595078103321
Dey Nandini  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances in Antibody Therapeutics
Recent Advances in Antibody Therapeutics
Autore Heo Yong-Seok
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (238 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato interleukin 33
ST2 receptor
scFv
C2_2E12
bladder cancer
antibodies
immune checkpoint inhibitors
antibody-drug conjugates
sacituzumab govitecan
enfortumab vedotin
erdafitinib
cost-effectiveness
G protein-coupled receptor
membrane protein
antigen
therapeutic antibody
anti-angiogenesis
delta-like ligand
irinotecan
paclitaxel
VEGF
SARS-CoV-2
spike protein
receptor-binding domain
phage display
monoclonal antibody
cytomegalovirus
peptide/major histocompatibility complex class I complex
T-cell-receptor-like antibody
affinity maturation
yeast surface display
combinatorial antibody library
agonist antibody
cell fate
bispecific antibodies
bioassays
mechanisms of action
binding assays
potency assays
atherosclerosis
inflammation
antibody therapy
blood-brain barrier
antibody
pharmacokinetics
disposition
biochemical and physicochemical properties
Fc binding
receptor-mediated transcytosis
brain shuttle
molecular Trojan horse
transferrin
anti-cancer antibody
antibody engineering
biophysical properties
computational methods
research cell bank
antibody therapeutics
recombinant antibodies
intracellular antibodies
single-chain antibody fragment
nanobody
Human papillomaviruses
HPV oncoproteins
HPV-associated cancer
HPV cancer therapy
asthma
refractory asthma
biomarker
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580204803321
Heo Yong-Seok  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Developments on Protein–Ligand Interactions : From Structure, Function to Applications
Recent Developments on Protein–Ligand Interactions : From Structure, Function to Applications
Autore de Brevern Alexandre G
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (282 p.)
Soggetto topico Research & information: general
Biology, life sciences
Biochemistry
Soggetto non controllato pimaricin thioesterase
protein-substrate interaction
macrocyclization
molecular dynamics (MD) simulation
pre-reaction state
folate
folate receptor
peptide conjugation
click reaction
biolayer interferometry
acetylcholinesterase
resistance
organophosphorus
pesticides
molecular modeling
lepidopterous
insects
conserved patterns
similarity
3D-patterns
epigenetics
protein-RNA interaction
RRM domain inhibitor
NMR fragment-based screening
TDP-43
galectin-1
gulopyranosides
fluorescence polarization
benzamide
selective
phospholipase C gamma 1
SLP76
virtual screening
pharmacophore mapping
molecular docking
molecular dynamics
caspase inhibition
protein-ligand binding free energy
Monte Carlo sampling
docking and scoring
molecular conformational sampling
procollagen C-proteinase enhancer-1
glycosaminoglycans
computational analysis of protein-glycosaminoglycan interactions
calcium ions
fragment-based docking
protein–ligand analysis
drug discovery and design
structure–activity relationships
bioremediation
High Energy Molecules
HMX
protein design
nitroreductase
flavoprotein
substrate specificity
pharmacophore
secretoglobin
odorant-binding protein
chemical communication
pheromone
N-phenyl-1-naphthylamine
in silico docking
protein–ligand interactions
2D interaction maps
ligand-binding assays
protein-ligand complexes
dataset
clustering
structural alignment
refinement
PD-1/PD-L1
immune checkpoint inhibitors
biphenyl-conjugated bromotyrosine
amino acid conjugation
amino-X
in silico simulation
IC50
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Recent Developments on Protein–Ligand Interactions
Recent Developments on Protein–Ligand Interactions
Record Nr. UNINA-9910566462703321
de Brevern Alexandre G  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Renal Cell Carcinoma
Renal Cell Carcinoma
Autore López José I
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (500 p.)
Soggetto topico Renal cell carcinoma
Kidneys - Cancer
Soggetto non controllato N-glycomapping
SMAD proteins
patient survival
pro-IL-1?
survival prediction
inflammation markers
tumor migration
prognostic factors
practical approach
circular RNAs in a clinico-genomic predictive model
glycomarkers
review
nephrectomy
uric acid
VEGF inhibitors
metabolic reprogramming
collecting duct carcinoma
curcumin
metabolome profiling
identification of circular RNAs
IL-2
experimental validation of circular RNA
Raf/MEK/ERK
HOT
PI3K/Akt/mTOR
pentose phosphate pathway
kidney cancer
LOT
mutation
RCC
polybromo-1
pale cell
MMP-9
gene expression
recurrence free survival
chromosomal loss
IL-1?
chronic kidney disease
glutathione transferase omega 2
label-free
glutathione transferase omega 1
emerging entity
copy number alteration
FOXO3
predictive role
tumor slice culture
tyrosine kinase inhibitors
PPP
ESC
CDKN1A expression
metastasis
PD-L1
diagnostic and prognostic markers
EVI1
copy number loss
RNA sequencing
NK cells
glutathione metabolism
clear cell renal cell carcinoma
renal cell cancer
proliferation
eosinophilic variant
Xp11 translocation renal cell carcinoma
prognosis
invasion
immune infiltration
IL4R?
FISH
11) translocation renal cell carcinoma
tumor microenvironment
metabolome
hyperosmolality
toxicity
ALK
drug sensitivity
t(6
copy number analysis
urine
genetic association
polymorphism
solute carrier proteins
kidney
metastatic ccRCC
molecular genetic features
recurrence-free survival
chromophobe renal cell carcinoma
unclassified renal tumor
overall survival
mTOR inhibitors
mTOR
JAK2
von Hippel-Lindau
miR-155-5p
glycoproteomics
PBRM1
miR-133b
survival
TFE3
TFEB
oncocytic renal tumor
immune checkpoint inhibitors
biomarker
MMP10
TCGA
ghrelin
EMT like
checkpoint inhibitors
MiT family translocation renal cell carcinoma
gene signature
sarcomatoid
transforming growth factor beta
clear cell Renal Cell Carcinoma
tumor adhesion
renal cancer
unclassified renal cell carcinoma
Papillary renal cell carcinoma (pRCC)
miR-146a-5p
renal cell
everolimus
integrins
cytoreductive nephrectomy
immunotherapy
predictive factors
immunohistochemistry
MTA2
IL13R?1
targeted therapy
intratumour heterogeneity
aurora A
TCA cycle
AMP-activated protein kinases
cancer-specific survival
programmed death-ligand 1
efficacy
renal cell carcinoma
anaplastic lymphoma kinase rearrangement
TFEB-amplified renal cell carcinoma
statins
cancer immunotherapy
microRNA
new entity
proteome profiling
ISBN 3-03928-639-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404087003321
López José I  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 1
Role of Medical Imaging in Cancers . Volume 1
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (312 pages)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557432103321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 2
Role of Medical Imaging in Cancers . Volume 2
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (228 p.)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557309503321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Small Cell Lung Cancer: A New Era Is Beginning?
Small Cell Lung Cancer: A New Era Is Beginning?
Autore Morabito Alessandro
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (150 p.)
Soggetto topico Medicine
Soggetto non controllato immune checkpoint inhibitors
extensive-stage small cell lung cancer
nivolumab
ipilimumab
pembrolizumab
atezolizumab
durvalumab
chemotherapy
small-cell lung cancer
lobectomy
pneumonectomy
radiotherapy
multimodal treatment
immunotherapy
SCLC
PARP
DDR
ICB
synthetic lethality
SLFN11
STING
pathology and classification of SCLC
biology of SCLC
immune-checkpoint inhibitors in SCLC
small cell lung cancer
Immunotherapy
extensive disease
lurbinectedin
gene pathway
pathobiology
targeted therapy
circulating tumor cells
prognostic biomarker
targeted agents
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Small Cell Lung Cancer
Record Nr. UNINA-9910557380603321
Morabito Alessandro  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Toxins and Cancer Therapy
Toxins and Cancer Therapy
Autore Snook Adam E
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (104 p.)
Soggetto topico Medicine
Soggetto non controllato immunotoxin
ribotoxin
α-sarcin
RNase T1
furin
intracellular trafficking
colorectal cancer
botulinum toxin
botulinum neurotoxin
cancer
cancer cells
neuropathic pain
post-surgical pain
parotid gland
submaxillary gland
gustatory hyperhidrosis
sialocele
parotid fistula
immunotherapy
vaccine
immune checkpoint inhibitors
adoptive cell therapy
cytokine therapy
Coley's Toxins
glioblastoma
drug discovery
cytotoxic necrotizing factor type 1
protein purification
recombinant protein production
shiga toxins
Gb3/CD77
apoptosis
ER stress
autophagy
Burkitt lymphoma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557123603321
Snook Adam E  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Urological Cancer 2021
Urological Cancer 2021
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (328 pages)
Soggetto topico Research
Chemistry
Soggetto non controllato bladder cancer
radiotherapy
radiosensitisation
molecular subtypes
preclinical studies
bladder cancer cell lines
latent cancer
prostate cancer
autopsy
prognostic index
prediction model
mortality
screening trial
renal cell carcinoma
PD-1
PD-L1
biomarkers
immune checkpoint inhibitors
prostatic neoplasms
positron-emission tomography
decision making
tumor thrombus
metastasectomy
postoperative complications
oncological outcomes
radical cystectomy
AHNAK2
prognosis
dog
comparative oncology
inflammation
prostatic atrophy
preneoplastic lesion
biomarker
urine
machine learning
TRIPOD
liquid biopsy
glutaminase
immunohistochemistry
in situ methods
prostate
PSMA-RLT
177Lu-PSMA
PSA
mCRPC
urinary bladder neoplasms
Bacillus Calmette-Guérin (BCG)
immunotherapy
divergent differentiation
variant morphology
survival
stereotactic body radiotherapy
frail patients
cancer
metastasis
genomic analysis
microenvironment
tumor ecology
game theory
fluorescence confocal microscopy
prostate biopsy
ablation margins
focal therapy
sphingosine 1-phosphate receptor 1
bladder carcinoma
cell migration
epithelial-mesenchymal transition
FTY-720
OIP5
papillary renal cell carcinoma
PLK1
tumorigenesis
therapy
image-guided
magnetic resonance imaging
ultrasonography
biopsy
abiraterone
enzalutamide
docetaxel
novel hormonal therapies
comparative effectiveness
real-world treatment pattern
metastatic prostate cancer
epiplakin
diagnosis
advanced urothelial carcinoma
immune checkpoint inhibitor
prognostic
tumour mutational board
genomic signatures
ctDNA
inflammatory indices
urothelial carcinoma
frailty
prognostic factor
psoas muscle
Hounsfield units
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576872803321
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui